CACNA1C and Timothy syndrome: Further, roscovitine, a cyclin-dependent kinase inhibitor which increased the voltage-dependent inactivation of CaV1.2 [254,255,256], restored the electrical and Ca2+ signaling properties of cardiomyocytes from Timothy syndrome patients.